Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

10.0%

2 terminated out of 20 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

20%

4 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed with results

Key Signals

75% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (4)
P 1 (6)
P 2 (3)
P 3 (2)
P 4 (2)

Trial Status

Unknown7
Completed6
Recruiting3
Withdrawn2
Terminated2

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT06209632Not ApplicableCompletedPrimary

Mirror Therapy Combined With Contralaterally Controlled Functional Electrical Stimulation for Peripheral Nerve Injury

NCT02359825Phase 1RecruitingPrimary

Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

NCT05541250Phase 1RecruitingPrimary

Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI)

NCT06003166Phase 2RecruitingPrimary

4-AP Peripheral Nerve Crossover Trial

NCT00953277Phase 4CompletedPrimary

Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer

NCT06071988Phase 3Unknown

Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy

NCT06071936Phase 3Unknown

Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy

NCT04270019Phase 1WithdrawnPrimary

Polyethylene Glycol to Improve Sensation Following Digital Nerve Laceration

NCT02034461Not ApplicableTerminated

Micro-Electrodes Implanted in a Human Nerve

NCT03147313Not ApplicableUnknownPrimary

Extracorporal Shock Wave Treatment to Improve Nerve Regeneration

NCT00950391Phase 1WithdrawnPrimary

Enhancement of Functional Recovery After Peripheral Nerve Injury With Tacrolimus

NCT02228928Phase 1CompletedPrimary

Study of Capsaicin Patch for the Management of Peripheral Neuropathic Pain

NCT02865317UnknownPrimary

Cortical Effects of Peripheral Nerve Injury At Birth

NCT02666456Unknown

The Influence of Sensory Phenotype on the Risk of Developing Neuropathic Pain

NCT02352649Phase 1UnknownPrimary

Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Peripheral Nerve Injury

NCT01302275Phase 4Completed

Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain

NCT01596491CompletedPrimary

Study of Possible Changes in QST After Application of Capsaicin on Patients With Peripheral Neuropathic Pain

NCT01088256Phase 2Terminated

Efficacy of Etoricoxib on Peripheral Hyperalgesia

NCT01554722Not ApplicableUnknownPrimary

Needle Nerve Contact in Ultrasound Guided Femoral Block

NCT01116362Phase 2CompletedPrimary

Comparing Primary With Secondary Repair of Based on Electrodiagnostic Assessment and Clinical Examination

Showing all 20 trials

Research Network

Activity Timeline